You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 146 No. 9, September 1986 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (24)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Necropsy Evidence of Detection Bias in the Diagnosis of Lung Cancer

Michael J. McFarlane, MD; Alvan R. Feinstein, MD; Carolyn K. Wells, MPH

Arch Intern Med. 1986;146(9):1695-1698.


Abstract

• The correct diagnosis had not been made during life in 26% of 153 patients with lung cancer found in necropsies performed between 1971 and 1982. The likelihood of a correct antemortem diagnosis showed distinctive gradients in relation to the patients' history and amount of cigarette smoking, symptomatic manifestations, and anatomic extensiveness of the cancers. However, cigarette smoking still exerted a diagnostic effect in patients with similar symptoms and similar degrees of anatomic spread. Furthermore, if a lesion was present, chest films were more likely to be radiologically interpreted as a cancer in smokers. The results suggest that smokers receive preferential consideration regarding the diagnosis of lung cancer. This detection bias can have adverse scientific consequences in depriving nonsmokers of suitable therapy, in leading to falsely high estimates of the true magnitude of the smoking/lung cancer association, and in distracting etiologic attention from other agents that may cause lung cancer.

(Arch Intern Med 1986;146:1695-1698)



Author Affiliations

From the Departments of Medicine (Dr Feinstein and Ms Wells) and Epidemiology (Dr Feinstein) and the Robert Wood Johnson Clinical Scholars Program (Drs McFarlane and Feinstein and Ms Wells), Yale University School of Medicine, New Haven, Conn; and the Cooperative Studies Program Coordinating Center, Veterans Administration Medical Center, West Haven, Conn (Dr Feinstein). Dr McFarlane is now with the University of Kansas Medical Center, Kansas City.


Footnotes

Accepted for publication Dec 9, 1985.

Reprint requests to Department of Internal Medicine, University of Kansas Medical Center, 39th and Rainbow Blvd, Kansas City, KS 66103 (Dr McFarlane).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

CT Screening for Lung Cancer: Are We Ready for Wide-Scale Application?
Aisner
Clin. Cancer Res. 2007;13:4951-4953.
FULL TEXT  

Lung cancer screening, overdiagnosis bias, and reevaluation of the Mayo Lung Project.
Patz
JNCI J Natl Cancer Inst 2006;98:724-725.
FULL TEXT  

Gender Disparities in Clinical Decision Making
Council on Ethical and Judicial Affairs, American et al.
JAMA 1991;266:559-562.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.